Expo Hub
Alzheimer’s
Care Pathway
Follow Rose on her journey
1Disease Modifying Therapy (DMT) in Alzheimer’s Disease comes with risks. Please refer to the specific DMT's prescribing information for side effects, contraindications, and risks
2Faktenzentrale: Demenz, DZNE, https://www.dzne.de/aktuelles/hintergrund/faktenzentrale/ 2024 Alzheimer’s Disease Facts and Figures, Alzheimer’s Association Cancer Today, International Agency for Research on Cancer, WHO
3Data on file.
4T1 contrast can also be acquired using gradient echo based imaging.
5Data courtesy of Wentworth-Douglas Hospital, Dover, New Hampshire, USA.
6syngo.via solutions consist of a broad variety of software options, which are medical devices in their own right. syngo.via solutions-based software options are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
7AI-Rad Companion Brain MR is not commercially available in all countries, and its future availability cannot be ensured
8Data courtesy of Lausanne University Hospital, Switzerland
9Courtesy of Northwell Health, USA.
10J. Cummings et al. Lecanemab: “Appropriate Use Recommendations.” The Journal of Prevention of Alzheimer’s Disease 2023. https://doi.org/10.14283/jpad.2023.30
https://www.fda.gov/drugs/drug-safety-andavailability/fda-recommend-additional-earlier-mrimonitoring-patients-alzheimers-disease-takingleqembi-lecanemab
G.D. Rabinovici et al. Donanemab: “Appropriate use recommendations.” The Journal of Prevention of Alzheimer’s Disease 2025. https://doi.org/10.1016/j.tjpad.2025.100150
https://www.fda.gov/drugs/drug-safety-andavailability/fda-recommend-additional-earlier-mrimonitoring-patients-alzheimers-disease-takingleqembi-lecanemab
G.D. Rabinovici et al. Donanemab: “Appropriate use recommendations.” The Journal of Prevention of Alzheimer’s Disease 2025. https://doi.org/10.1016/j.tjpad.2025.100150
11Courtesy of Mount Sinai School of Medicine, USA
12Courtesy of CHUV, Lausanne, Switzerland
13Disease Modifying Therapy (DMT) in Alzheimer’s Disease comes with risks. Please refer to the specific DMT's prescribing information for side effects, contraindications, and risks.
14For more information: https://www.cortechs.ai/neuroquant-aria/
The information shown herein refers to products of 3rd party manufacturer’s and thus are in their regulatory responsibility. Please contact the 3rd party manufacturer for further information.
Courtesy of The Alfred Hospital, Melbourne, Australia
The information shown herein refers to products of 3rd party manufacturer’s and thus are in their regulatory responsibility. Please contact the 3rd party manufacturer for further information.
Courtesy of The Alfred Hospital, Melbourne, Australia